Separate domestic and international initiatives to support the development and production of medical radioisotopes have been announced in Canada, Germany, Japan and the USA. These include a federal award of USD35 million to support the commercial production of molybdenum-99 in the USA; a new linear accelerator-based technique for production of actinium-225 in Japan; and a Canadian-German collaboration to explore the production of Ac-225.